Correlation Between Eli Lilly and Akebia Ther

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eli Lilly and Akebia Ther at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and Akebia Ther into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eli Lilly and and Akebia Ther, you can compare the effects of market volatilities on Eli Lilly and Akebia Ther and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of Akebia Ther. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and Akebia Ther.

Diversification Opportunities for Eli Lilly and Akebia Ther

-0.13
  Correlation Coefficient

Good diversification

The 3 months correlation between Eli and Akebia is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and Akebia Ther in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akebia Ther and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with Akebia Ther. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akebia Ther has no effect on the direction of Eli Lilly i.e., Eli Lilly and Akebia Ther go up and down completely randomly.

Pair Corralation between Eli Lilly and Akebia Ther

Considering the 90-day investment horizon Eli Lilly is expected to generate 1.89 times less return on investment than Akebia Ther. But when comparing it to its historical volatility, Eli Lilly and is 3.42 times less risky than Akebia Ther. It trades about 0.06 of its potential returns per unit of risk. Akebia Ther is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  195.00  in Akebia Ther on December 27, 2024 and sell it today you would lose (3.00) from holding Akebia Ther or give up 1.54% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Eli Lilly and  vs.  Akebia Ther

 Performance 
       Timeline  
Eli Lilly 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Eli Lilly and are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain essential indicators, Eli Lilly may actually be approaching a critical reversion point that can send shares even higher in April 2025.
Akebia Ther 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Akebia Ther are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental drivers, Akebia Ther sustained solid returns over the last few months and may actually be approaching a breakup point.

Eli Lilly and Akebia Ther Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eli Lilly and Akebia Ther

The main advantage of trading using opposite Eli Lilly and Akebia Ther positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, Akebia Ther can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akebia Ther will offset losses from the drop in Akebia Ther's long position.
The idea behind Eli Lilly and and Akebia Ther pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Transaction History
View history of all your transactions and understand their impact on performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance